nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Angiopoietin decoy secreted at tumor site impairs tumor growth and metastases by inducing local inflammation and altering neoangiogenesis
|
Melani, Cecilia |
|
2004 |
53 |
7 |
p. 600-608 |
artikel |
2 |
CD44v6: a target for antibody-based cancer therapy
|
Heider, Karl-Heinz |
|
2004 |
53 |
7 |
p. 567-579 |
artikel |
3 |
Enhancement of cytotoxic T-lymphocyte responses in patients with gastrointestinal malignancies following vaccination with CEA peptide–pulsed dendritic cells
|
Matsuda, Kenji |
|
2004 |
53 |
7 |
p. 609-616 |
artikel |
4 |
Identification of an antigenic peptide derived from the cancer-testis antigen NY-ESO-1 binding to a broad range of HLA-DR subtypes
|
Neumann, Frank |
|
2004 |
53 |
7 |
p. 589-599 |
artikel |
5 |
Identification of an antigenic peptide derived from the cancer-testis antigen NY-ESO-1 binding to a broad range of HLA-DR subtypes
|
Neumann, Frank |
|
|
53 |
7 |
p. 589-599 |
artikel |
6 |
Phase I/II trial of immunogenicity of a human papillomavirus (HPV) type 16 E7 protein–based vaccine in women with oncogenic HPV-positive cervical intraepithelial neoplasia
|
Hallez, Sophie |
|
2004 |
53 |
7 |
p. 642-650 |
artikel |
7 |
Pilot study of treatment of biochemotherapy-refractory stage IV melanoma patients with autologous dendritic cells pulsed with a heterologous melanoma cell line lysate
|
Vilella, R. |
|
2004 |
53 |
7 |
p. 651-658 |
artikel |
8 |
T-cell-mediated lysis of B cells induced by a CD19xCD3 bispecific single-chain antibody is perforin dependent and death receptor independent
|
Gruen, Michael |
|
2004 |
53 |
7 |
p. 625-632 |
artikel |
9 |
α-Tocopheryl succinate sensitizes established tumors to vaccination with nonmatured dendritic cells
|
Ramanathapuram, Lalitha V. |
|
2004 |
53 |
7 |
p. 580-588 |
artikel |
10 |
Vaccination with p53-peptide–pulsed dendritic cells, of patients with advanced breast cancer: report from a phase I study
|
Svane, Inge Marie |
|
2004 |
53 |
7 |
p. 633-641 |
artikel |
11 |
WT1 peptide vaccination combined with BCG-CWS is more efficient for tumor eradication than WT1 peptide vaccination alone
|
Nakajima, Hiroko |
|
2004 |
53 |
7 |
p. 617-624 |
artikel |